Axonics Modulation Technologies, Inc. (AXNX): Price and Financial Metrics
AXNX Price/Volume Stats
| Current price | $70.98 | 52-week high | $71.05 |
| Prev. close | $70.45 | 52-week low | $55.09 |
| Day low | $70.37 | Volume | 4,233,300 |
| Day high | $71.05 | Avg. volume | 713,457 |
| 50-day MA | $69.83 | Dividend yield | N/A |
| 200-day MA | $68.36 | Market Cap | 3.63B |
AXNX Stock Price Chart Interactive Chart >
Axonics Modulation Technologies, Inc. (AXNX) Company Bio
Axonics Modulation Technologies, Inc. is a medical technology company, which engages in the design, development, and commercialization of sacral neuromodulation (SNM) solutions. The company focuses on the treatment of patients with overactive bladder (OAB), fecal incontinence (FI), and urinary retention (UR). It offers rechargeable SNM system, which delivers mild electrical pulses to the targeted sacral nerve in order to restore normal communication to and from the brain to reduce the symptoms of OAB, FI, and UR. The company was founded by Guang Qiang Jiang, Danny L. Dearen, Timothy Deer, and Michael V. Williamson in 2013 and is headquartered in Irvine, CA.
AXNX Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
AXNX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | 5.74% |
| 3-year | 20.96% |
| 5-year | 79.56% |
| YTD | N/A |
| 2024 | 0.00% |
| 2023 | -0.48% |
| 2022 | 11.66% |
| 2021 | 12.18% |
| 2020 | 80.15% |